+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Kinetics of inhibition of soluble peripheral nerve esterases by PMSF: a non-stable compound that potentiates the organophosphorus-induced delayed neurotoxicity



Kinetics of inhibition of soluble peripheral nerve esterases by PMSF: a non-stable compound that potentiates the organophosphorus-induced delayed neurotoxicity



Archives of Toxicology 86(5): 767-777



The kinetic analysis of esterase inhibition by acylating compounds (organophosphorus carbamates and sulfonyl fluorides) is sometimes unable to yield consistent results by fitting simple inhibition kinetic models to experimental data of complex systems. In this work, kinetic data were obtained for phenylmethylsulfonyl fluoride (PMSF) tested at different concentrations incubated for up to 3 h with soluble fraction of chicken peripheral nerve. PMSF is a protease and esterase inhibitor causing protection or potentiation of the organophosphorus-induced delayed neuropathy and is unstable in water solution. The target of the promotion effect was proposed to be a soluble esterase not yet identified. A kinetic model equation was deduced assuming a multienzymatic system with three different molecular phenomena occurring simultaneously: (1) inhibition, (2) spontaneous chemical hydrolysis of the inhibitor and (3) ongoing inhibition (inhibition during the substrate reaction). A three-dimensional fit of the model was applied for analyzing the experimental data. The best-fitting model is compatible with a resistant component (16.5-18%) and two sensitive enzymatic entities (both 41%). The corresponding second-order rate constants of inhibition (ki = 12.04 × 10⁻² and 0.54 × 10⁻² μM⁻¹ min⁻¹, respectively) and the chemical hydrolysis constant of PMSF (kh = 0.0919 min⁻¹) were simultaneously estimated. These parameters were similar to those deduced in fixed-time inhibition experiments. The consistency of results in both experiments was considered an internal validation of the methodology. The results were also consistent with a significant ongoing inhibition. The proportion of enzymatic components showed in this work is similar to those previously observed in inhibition experiments with mipafox, S9B and paraoxon, demonstrating that this kinetic approach gives consistent results in complex enzymatic systems.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036345940

Download citation: RISBibTeXText

PMID: 22354540

DOI: 10.1007/s00204-012-0817-3


Related references

A new mathematical processing for the kinetics of inhibition of esterases by organophosphorus compounds The inhibition of peripheral nerve soluble esterases by mipafox as a model. Toxicology Letters (Shannon) 116(Suppl 1): 73, September 1st, 2000

The inhibition of the high sensitive peripheral nerve soluble esterases by mipafox. A new mathematical processing for the kinetics of inhibition of esterases by organophosphorus compounds. Toxicology Letters 151(1): 171-181, 2004

The significance of inhibition of nonspecific esterases in the development of organophosphorus induced delayed neurotoxicity. Brzin, M , E A Barnard And D Sket (Ed ) Cholinesterases: Fundamental And Applied Aspects; 2nd International Meeting; Bled, Yugoslavia, Sept 17-21, 1983 Xiv+527p Walter De Gruyter: Berlin, West Germany; New York, N Y , Usa Illus 447-462, 1984

Potentiation of organophosphorus compound-induced delayed neurotoxicity (OPIDN) in the central and peripheral nervous system of the adult hen: distribution of axonal lesions. Journal of Toxicology and Environmental Health 51(6): 571-590, 1997

Organophosphorus inhibition and heat inactivation kinetics of particulate and soluble forms of peripheral nerve neuropathy target esterase. Journal of Biochemical Toxicology 10(4): 211-218, 1995

Studies on the molecular pathogenesis of organophosphorus compound-induced delayed neurotoxicity (OPIDN). Insecticide action: from molecule to organism edited by Toshio Narahashi and ice E Chambers: 216, 1989

The role of protein phosphorylation in organophosphorus compound induced delayed neurotoxicity opidn. Journal of Neurochemistry 52(SUPPL): S198, 1989

Effects of prednisolone and complex of vitamin B1, B2, B6 and B12 on organophosphorus compound-induced delayed neurotoxicity. Journal of Occupational Health 46(5): 359-364, 2004

Possible role of endogenous protein phosphorylation in organophosphorus compound induced delayed neurotoxicity. Narahashi, T (Ed ) Cellular And Molecular Neurotoxicology Meeting, San Diego, Calif , Usa, Aug 26-27, 1983 Xv+304p Raven Press: New York, N Y , Usa Illus 265-284, 1984

Organophosphorus compound-induced delayed neurotoxicity in white leghorn hens assessed by Fluoro-Jade. International Journal of Toxicology 23(4): 259-266, 2004

Neurotoxic esterase in cultured cells an in vitro alternative for the study of organophosphorus compound induced delayed neurotoxicity. Goldberg, A M (Ed ) Alternative Methods in Toxicology, Vol 3 in Vitro Toxicology: A Progress Report From The Johns Hopkins Center For Alternatives to Animal Testing; Third Symposium Xviii+722p Mary Ann Liebert, Inc : New York, N Y , Usa Illus 455-466, 1985, 1986

Properties of phenyl valerate esterase activities from chicken serum are comparable with soluble esterases of peripheral nerves in relation with organophosphorus compounds inhibition. Toxicology Letters 142(1/2): 1-10, 2003

Neuropathologic effects of phenylmethylsulfonyl fluoride (PMSF)-induced promotion and protection in organophosphorus ester-induced delayed neuropathy (OPIDN) in hens. Neurotoxicology 20(5): 749-759, 1999

In vivo protection from DFP inhibition of peripheral nerve soluble esterases by paraoxon. Toxicology Letters (Shannon) 135(Suppl 1): S157, September 15th, 2002

"Delayed neurotoxicity produced by an organophosphorus compound (Sumithion)". Archives of Toxicology 58(2): 123-124, 1985